StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
ABPO

Abpro Holdings, Inc.

ABPO OTC Biological Products, (No Diagnostic Substances) EDGAR ↗
$0.26
+0.05 +24.76%

Key statistics

from XBRL data in SEC filings
Market cap
$1.54M
Revenue (TTM)
$183K
Net income (TTM)
-$33.0K
EPS (TTM)
$0.76
P/E ratio
0.3
Dividend yield
Free cash flow
-$6.05M
Cash
$5.41M
Total assets
$6.87M
Gross margin
52-week range
$0.09 – $9.30

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Delisting notice or listing-rule failure Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 20, 2026 10-K/A Fiscal year ended 2025-12-31 May 1, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Delisting notice or listing-rule failure Feb 20, 2026 8-K Delisting notice or listing-rule failure; Director or officer change Feb 11, 2026 8-K Director or officer change Feb 3, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Director or officer change Jan 23, 2026 8-K Regulation FD disclosure Jan 6, 2026 8-K Regulation FD disclosure Dec 15, 2025 8-K Regulation FD disclosure Dec 9, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K/A Regulation FD disclosure Nov 4, 2025 8-K Regulation FD disclosure Nov 4, 2025 8-K Regulation FD disclosure Nov 3, 2025 8-K Amended charter or bylaws Oct 22, 2025 8-K Delisting notice or listing-rule failure Oct 17, 2025 8-K Shareholder vote results Oct 14, 2025 8-K Delisting notice or listing-rule failure Oct 3, 2025 8-K Director or officer change Oct 2, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Director or officer change Jul 24, 2025 8-K Regulation FD disclosure Jun 17, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Regulation FD disclosure Apr 28, 2025 8-K Entered a material agreement; Took on a direct financial obligation Apr 24, 2025 8-K Delisting notice or listing-rule failure Apr 16, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Previously issued financials not reliable Apr 15, 2025 8-K Shareholder vote results Apr 8, 2025 8-K Delisting notice or listing-rule failure Apr 8, 2025 8-K Regulation FD disclosure Mar 26, 2025 8-K Director or officer change Mar 7, 2025 8-K Modified rights of security holders Mar 6, 2025 8-K Regulation FD disclosure Feb 21, 2025 8-K Regulation FD disclosure Dec 12, 2024 8-K Changed accountants Dec 10, 2024 8-K Director or officer change Nov 29, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Item 5.06 Nov 26, 2024 10-Q Quarter ended 2024-09-30 Nov 26, 2024